Amphetamine induced endogenous opioid release in the human brain detected with [11C]carfentanil PET: Replication in an independent cohort

International Journal of Neuropsychopharmacology

Volumn 17, Issue 12, 2014, Pages 2069-2074

  Mick, Inge ^a   Myers, Jim ^a   Stokes, Paul R A ^a,b   Erritzoe, David ^a   Colasanti, Alessandro ^a,b,c   Bowden Jones, Henrietta ^d   Clark, Luke ^e   Gunn, Roger N ^a,c   Rabiner, Eugenii A ^b,c   Searle, Graham E ^c   Waldman, Adam D ^a   Parkin, Mark C ^b   Brailsford, Alan D ^b   Nutt, David J ^a   Lingford Hughes, Anne R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Imanova Ltd   (United Kingdom)

^d CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amphetamine, 11C carfentanil; Opioid system; PET

Indexed keywords

AMPHETAMINE; CARBON; CARFENTANIL; CENTRAL STIMULANT AGENT; FENTANYL; OPIATE PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; ANALOGS AND DERIVATIVES; BLOOD; BRAIN; BRAIN MAPPING; COHORT ANALYSIS; DRUG EFFECTS; HUMAN; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ADULT; AMPHETAMINE; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; CENTRAL NERVOUS SYSTEM STIMULANTS; COHORT STUDIES; FENTANYL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OPIOID PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84939876749     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000704     Document Type: Article

References (18)

1. Colasanti A, Searle GE, Long CJ, Hill SP, Reiley RR, Quelch D, Erritzoe D, Tziortzi AC, Reed LJ, Lingford-Hughes AR, Waldman AD, Schruers KR, Matthews PM, Gunn RN, Nutt DJ, Rabiner EA (2012) Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry 72:371-377.
2. Guterstam J, Jayaram-Lindstrom N, Cervenka S, Frost JJ, Farde L, Halldin C, Franck J (2013) Effects of amphetamine on the human brain opioid system-a positron emission tomography study. Int J Neuropsychoph 16:763-769.
3. Hiller JM, Fan LQ (1996) Laminar distribution of the multiple opioid receptors in the human cerebral cortex. Neurochem Res 21:1333-1345.
4. Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Wang H, Ni L, Walker SJ, Mickey BJ, Korycinski ST, Koeppe RA, Crocker JK, Langenecker SA, Zubieta JK (2013) Response of the mu-opioid system to social rejection and acceptance. Mol Psychiatry 18:1211-1217.
5. Koepp MJ, Hammers A, Lawrence AD, Asselin MC, Grasby PM, Bench CJ (2009) Evidence for endogenous opioid release in the amygdala during positive emotion. Neuroimage 44:252-256.
6. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
7. Love TM, Stohler CS, Zubieta JK (2009) Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 66:1124-1134.
8. Maarrawi J, Peyron R, Mertens P, Costes N, Magnin M, Sindou M, Laurent B, Garcia-Larrea L (2013) Brain opioid receptor density predicts motor cortex stimulation efficacy for chronic pain. Pain 154:2563-2568.
9. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314.
10. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM (2010) Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab 30:1682-1706.
11. Petrovic P, Pleger B, Seymour B, Kloppel S, De Martino B, Critchley H, Dolan RJ (2008) Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci 28:10509-10516.
12. Rabiner EA, Beaver J, Makwana A, Searle G, Long C, Nathan PJ, Newbould RD, Howard J, Miller SR, Bush MA, Hill S, Reiley R, Passchier J, Gunn RN, Matthews PM, Bullmore ET (2011) Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry 16:826-835, 785.
13. Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S, Plisson C, Miller SR, Huiban M, Beaver JD, Gunn RN, Laruelle M, Rabiner EA (2012) Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J Cereb Blood Flow Metab 32:127-136.
14. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143-155.
15. Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M, Laruelle M, Rabiner EA, Gunn RN (2011) Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 54:264-277.
16. Van Kammen DP, Murphy DL (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215-224.
17. Williams TM, Davies SJ, Taylor LG, Daglish MR, Hammers A, Brooks DJ, Nutt DJ, Lingford-Hughes A (2009) Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study. Eur Neuropsychopharmacol 19:740-748.
18. Zubieta JK, Stohler CS (2009) Neurobiological mechanisms of placebo responses. Ann NY Acad Sci 1156:198-210.